Novel amorphous form of erlotinib hydrochloride and its solid amorphous dispersion
申请人:Huang Le
公开号:US20060154941A1
公开(公告)日:2006-07-13
The present invention relates to novel amorphous form of [6,7-Bis(2-methoxy-ethoxy)-quinazolin-4-yl]-(3-ethynyl-phenyl) (erlotinib hydrochloride), to solid amorphous dispersion of erlotinib hydrochloride and a carrier such as PVP or solid PEG, to processes for their preparations, to pharmaceutical compositions containing them and to method of treatment using the same. The amorphous form or solid amorphous dispersion of erlotinib hydrochloride obtained in this invention is useful in preparing pharmaceutical dosage forms.
本发明涉及[6,7-双(2-甲氧基乙氧基)-喹唑啉-4-基]-(3-乙炔基苯基)(盐酸厄洛替尼)的新型非晶态形式,以及盐酸厄洛替尼和载体(如PVP或固态PEG)的固体非晶态分散体,它们的制备方法,含有它们的制药组合物以及使用它们的治疗方法。本发明所获得的盐酸厄洛替尼非晶态形式或固体非晶态分散体在制备制药剂型方面非常有用。